Disulfiram, an anti-alcoholism drug, has long been clinically used for the treatment of chronic alcoholism, and previous research revealed its inhibition on RANKL-induced osteoclastogenesis [15]. The gene discussed is TNFSF11; the disease is alcohol drinking.